Electronic Cigarette Use in 12 European Countries: Results From the TackSHS Survey
Por:
Gallus S., Lugo A., Stival C., Cerrai S., Clancy L., Filippidis F.T., Gorini G., Lopez M.J., López-Nicolás Á., Molinaro S., Odone A., Soriano J.B., Tigova O., van den Brandt P.A., Vardavas C.I., Fernandez E., the TackSHS Project Investigators
Publicada:
1 jun 2023
Ahead of Print:
15 abr 2022
Resumen:
Background: Limited data on electronic cigarette prevalence, patterns, and settings of use are available from several European countries.Methods: Within the TackSHS project, a face-to-face survey was conducted in 2017-2018 in 12 European countries (Bulgaria, England, France, Germany, Greece, Ireland, Italy, Latvia, Poland, Portugal, Romania and Spain). Overall, 11,876 participants, representative of the population aged > 15 years in each country, provided information on electronic cigarette.Results: 2.4% (95% confidence interval [CI], 2.2-2.7%) of the subjects (2.5% among men and 2.4% among women; 0.4% among never, 4.4% among current-and 6.5% among ex-smokers) reported current use of electronic cigarette, ranging from 0.6% in Spain to 7.2% in England. Of the 272 electronic cigarette users, 52.6% were dual users (ie, users of both electronic and conventional cigarettes) and 58.8% used liquids with nicotine. In all, 65.1% reported using electronic cigarette in at least one indoor setting where smoking is forbidden; in particular, at workplaces (34.9%) and bars and restaurants (41.5%). Multivariable logistic regression analysis showed that electronic cigarette use was lower among older individuals (P for trend <0.001) and higher among individuals with high level of education (P for trend = 0.040). Participants from countries with higher tobacco cigarette prices more frequently reported electronic cigarette use (odds ratio 3.62; 95% CI, 1.80-7.30).Conclusion: Considering the whole adult population of these 12 European countries, more than 8.3 million people use electronic cigarettes. The majority of users also smoked conventional cigarettes, used electronic cigarettes with nicotine, and consumed electronic cigarettes in smoke-free indoor areas.
Filiaciones:
Gallus S.:
Ist Ric Farmacolog Mario Negri IRCCS, Dept Environm Hlth Sci, Lab Lifestyle Epidemiol, Via Mario Negri 2, I-20156 Milan, Italy
Lugo A.:
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
Stival C.:
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
Cerrai S.:
Ist Ric Farmacolog Mario Negri IRCCS, Dept Environm Hlth Sci, Milan, Italy
Clancy L.:
Natl Res Council Italy IFC CNR, Inst Clin Physiol, Epidemiol & Hlth Res Lab, Pisa, Italy
Filippidis F.T.:
TobaccoFree Res Inst Ireland, Dublin, Ireland
Gorini G.:
Imperial Coll London, Dept Primary Care & Publ Hlth, London, England
Lopez M.J.:
Prevent & Res Inst ISPRO, Oncol Network, Florence, Italy
Agencia Salut Publ Barcelona, Barcelona, Spain
Univ Pompeu Fabra, Dept Ciencies Expt Salut DCEXS i, Barcelona, Spain
Consortium Biomed Res Epidemiol & Publ Hlth CIBERE, Madrid, Spain
López-Nicolás Á.:
Sant Pau Inst Biomed Res IIB Sant Pau, Barcelona, Spain
Molinaro S.:
Ist Ric Farmacolog Mario Negri IRCCS, Dept Environm Hlth Sci, Milan, Italy
Odone A.:
Ist Ric Farmacolog Mario Negri IRCCS, Dept Environm Hlth Sci, Milan, Italy
Polytech Univ Cartagena UPCT, Cartagena, Spain
Univ Vita Salute San Ra ff aele, Sch Med, Milan, Italy
Soriano J.B.:
Natl Res Council Italy IFC CNR, Inst Clin Physiol, Epidemiol & Hlth Res Lab, Pisa, Italy
TobaccoFree Res Inst Ireland, Dublin, Ireland
Univ Pavia, Dept Publ Hlth Expt & Forens Med, Pavia, Italy
Hosp Univ Princesa IISP, Madrid, Spain
Tigova O.:
TobaccoFree Res Inst Ireland, Dublin, Ireland
Imperial Coll London, Dept Primary Care & Publ Hlth, London, England
Prevent & Res Inst ISPRO, Oncol Network, Florence, Italy
Agencia Salut Publ Barcelona, Barcelona, Spain
Hosp Univ Princesa IISP, Madrid, Spain
Consortium Biomed Res Resp Dis CIBERES, Madrid, Spain
Inst Invest Biomed Bellvitge, Epidemiol & Publ Hlth Res Programme, Tobacco Control Res Grp, IDIBELL, Barcelona, Spain
Inst Catala Oncol, WHO collaborating Ctr tobacco control, Tobacco Unit, ICO, Barcelona, Spain
van den Brandt P.A.:
Univ Pompeu Fabra, Dept Ciencies Expt Salut DCEXS i, Barcelona, Spain
Univ Barcelona, Sch Med & Hlth Sci, Campus Bellvitge, Barcelona, Spain
Maastricht Univ Med Ctr, Sch Oncol & Dev Biol, Dept Epidemiol, GROW, Maastricht, Netherlands
Vardavas C.I.:
Ist Ric Farmacolog Mario Negri IRCCS, Dept Environm Hlth Sci, Milan, Italy
Maastricht Univ, Sch Publ Hlth & Primary Care,Med Ctr, Dept Epidemiol, CAPHRI, Maastricht, Netherlands
Hellen Canc Soc, Athens, Greece
Univ Crete, Sch Med, Iraklion, Greece
Fernandez E.:
TobaccoFree Res Inst Ireland, Dublin, Ireland
Imperial Coll London, Dept Primary Care & Publ Hlth, London, England
Prevent & Res Inst ISPRO, Oncol Network, Florence, Italy
Agencia Salut Publ Barcelona, Barcelona, Spain
Consortium Biomed Res Resp Dis CIBERES, Madrid, Spain
Inst Invest Biomed Bellvitge, Epidemiol & Publ Hlth Res Programme, Tobacco Control Res Grp, IDIBELL, Barcelona, Spain
Inst Catala Oncol, WHO collaborating Ctr tobacco control, Tobacco Unit, ICO, Barcelona, Spain
Green Published, gold, All Open Access, Gold, Green
|